Accutane Did Not Provide Adequate Warning
Three Appellate Court Judges in New Jersey reinstated cases against Hoffman-La Roche Inc. and Roche Laboratories Inc. stating that the drug maker’s warning on the adverse effects of the drug Accutane did not adequately warn that the acne drug caused inflammatory bowel disease. The drug companies did have a warning on the drug packaging which stated that Accutane was “associated” with inflammatory bowel disease but the Appellate Court held that the word “associated” wasn’t strong enough and the warning failed to warn that Accutane caused inflammatory bowel disease. (more…)